Yann‐Fuu Kou

Assistant Professor

Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Objective To determine the frequency of aspiration resolution after recurrent laryngeal nerve (RLN) reinnervation among children with dysphagia. Study Design Case series with chart review. Methods All pediatric RLN reinnervations between January 2013 and December 2022 at a tertiary aerodigestive program were included. Only children completing video fluoroscopic swallow studies (VFSS) prior to the RLN procedure were analyzed. Postoperative outcomes included swallowing function from VFSS, including thin liquid aspiration. Results Twenty‐four RLN reinnervations were reviewed, with six children obtaining both preoperative and postoperative VFSS. Following RLN reinnervation, no patients were noted to aspirate, and all patients had advancement in their diet consistencies. Conclusions Resolution of dysphagia and advancement of the oral diet after RLN reinnervation is common among children with aspiration and unilateral vocal fold immobility. Long‐term improvement of swallowing function in children with unilateral vocal cord paralysis corrected by RLN reinnervation must be examined further. Level of Evidence 4.

Year:

2025

Objective The objective of this study is to determine the impact of an intensive and a less intensive speech therapy regimen on pediatric sialorrhea patient and caregiver quality of life (QoL) as described by drooling impact scales (DIS). Methods A retrospective chart review included all pediatric patients from a secretion management clinic. There were two outpatient speech therapy programs: intensive (4 sessions/week for 3 weeks) and less intensive (2 sessions/week for 3 months). Both regimens included similar interventions including neuromuscular electrical stimulation and facial taping. The primary outcome measure was reduction in caregiver reported DIS after completing their designated program. Children observed without therapy also obtained DIS assessments overtime to measure potential changes in QoL. Results There were 49 patients included in the study with a mean age of 7.5 years (SD = 4.6). The most common comorbidities were global developmental delay ( n = 47; 96%), epilepsy ( n = 35; 71%), and cerebral palsy ( n = 32; 65%). After initial evaluation, 30 patients underwent speech therapy with significantly improved DIS scores compared to the 19 who had no therapy (43.4 vs. 54.5, p = 0.03). Of these 30, 16 (33%) underwent intensive therapy with mean DIS improving from 63.5 to 47.2 ( p = 0.006). Fourteen (29%) completed the less intensive regimen with mean DIS improving from 51.9 to 39.1 ( p = 0.07). There were 19 (39%) patients who underwent no therapy and mean DIS remained unchanged from 55.6 to 54.5 ( p = 0.86). Conclusion Sialorrhea can drastically impact patients and their families. An intensive speech therapy program is associated with improved QoL as described by the DIS. Speech therapy should be considered as an effective treatment modality to improve outcomes for pediatric sialorrhea. Level of Evidence 2.

Year:

2025

Objectives To investigate demographic data and airway management techniques for patients with congenital tracheal stenosis (CTS) during the preoperative, intraoperative, and postoperative periods. Study Design A retrospective chart review. Methods This study was a retrospective case series at a single tertiary care pediatric medical center. It encompassed all children diagnosed with CTS who underwent slide tracheoplasty from January 2001 through December 2018. Exclusion criteria were acquired stenosis, tracheomalacia, patients without a confirmed diagnosis of CTS, and those with missing data. Patient demographics and details of airway management were collected and analyzed. Results A total of 148 patients met the inclusion criteria. The most common etiology of CTS was congenital tracheal rings (90.5%). The median age at surgery was 9 months (interquartile range [IQR] 3.3–35.4), and the median stenosis length was 4.0 cm (IQR 3.5–5.4). The most frequent comorbidities were genetic diseases, prematurity, and preoperative intubation. The most common related cardiac comorbidities were pulmonary artery sling, patent ductus arteriosus, atrial septal defect, ventricular septal defect, and tetralogy of Fallot. Most of the patients with CTS exhibited 50% to 80% stenosis. Most of the patients underwent thoracic approach slide tracheoplasty. Airway management was primarily accomplished using an oral or nasal endotracheal tube preoperatively, cardiopulmonary bypass during surgical repair, and an oral or nasal endotracheal tube during closure and the postoperative period. Conclusions Slide tracheoplasty is an effective treatment for congenital tracheal stenosis. Coordinated airway management between the anesthesia and surgical teams is crucial. Appropriate planning yields the best patient outcomes. Level of Evidence 4 Laryngoscope , 135:1506–1510, 2025

Year:

2024

Objective To estimate the incidence and identify predictors of pediatric tracheostomy patients who transition into adulthood with a tracheostomy. Methods We conducted a retrospective analysis of pediatric tracheostomy patients treated at a single tertiary care pediatric hospital between 2009 and 2022. Patient demographics, comorbidities, tracheostomy outcomes, including decannulation and mortality rates, and the status of those alive with a tracheostomy at adulthood were compared. Results Of the 663 children who underwent a tracheostomy, 103 (15.5%) would have surpassed 18 years by September 1, 2023. Detailed breakdown: 26 (25%) were alive with a tracheostomy, 35 (34%) had been decannulated, 25 (24%) had passed away, and 17 (16.5%) were lost to follow‐up. Patients who retained their tracheostomies into adulthood were more likely to be older at tracheostomy placement (mean age 14.3 vs. 1.7 years, p < 0.001), Hispanic (43.7% vs. 30.5%, p = 0.003), not ventilated at initial discharge (41% vs. 24%, p < 0.001), and have severe neurocognitive disabilities (72% vs. 53%, p < 0.001). Logistic regression identified older age at tracheostomy placement (OR = 1.35, 95% CI [1.24–1.48]) and severe neurocognitive disability (OR = 6.20, 95% CI [2.13–18.09]) as significant predictors of maintaining a tracheostomy into adulthood. Conclusions Older age at tracheostomy placement and severe neurocognitive disabilities significantly predict the transition of pediatric tracheostomy patients to adult care with their tracheostomies. These findings highlight the need for specialized transition programs tailored to the needs of this unique population. Level of Evidence 4 Laryngoscope , 135:1186–1191, 2025

Year:

2024

Objectives The objective of this study is to determine the time to ventilator liberation and decannulation after tracheostomy placement in children with bronchopulmonary dysplasia (BPD) and pulmonary hypertension. Methods A prospective cohort study included all children (<18 years old) who underwent tracheostomy between 2015 and 2021 with or without a diagnosis of BPD. The primary outcomes were time to ventilator liberation, tracheostomy decannulation, or death with tracheostomy in place. Results A total of 303 children met inclusion with a median (interquartile range [IQR]) age at tracheostomy of 6.9 (IQR: 4.0–49.5) months. A diagnosis of BPD was made for 42% ( N = 127) and this group was younger (5.1 vs. 24.5 months, p < .001) and more often had pulmonary hypertension (68% vs. 24%, p < .001). Children with BPD spent a median of 2.9 years (IQR: 1.6–4.0) on ventilation compared to 1.9 years (IQR: 0.9–3.7) for children without BPD ( p = .009). The time to decannulation was greater among children with BPD (3.4 vs. 1.8 years, p < .001). However, unadjusted estimates of ventilator liberation (hazard ratio [HR]: 1.05, 95% confidence interval [95% CI]: 0.77–1.44) and decannulation (HR: 1.11, 95% CI: 0.74–1.66) over time were not prolonged by BPD. Pulmonary hypertension was associated with shorter time to death (adjusted HR [aHR] = 1.99, 95% CI: 1.17–3.38, p = .01), while BPD was associated with longer time to death (aHR: 0.38, 95% CI: 0.22–0.67, p = .001). Conclusion BPD is associated with increased ventilation and duration of tracheostomy but over time many children with BPD will wean off the ventilator and be decannulated. Pulmonary hypertension and not BPD is associated with increased time to death after tracheostomy.

Year:

2024

Objectives To determine the incidence of subglottic stenosis (SGS) in children after tracheostomy and identify risk factors for development. Study Design Retrospective cohort. Methods All patients (<18 years) undergoing tracheostomy at a tertiary children's hospital between 2015 and 2020 were included. Patients with a direct laryngoscopy (DL) concurrent with tracheostomy and a subsequent DL were included. Medical records, including operative reports, were reviewed to identify subglottic stenosis and associated risk factors. Results A total of 140 patients were included with mean age at tracheostomy of 2.4 years (standard deviation [SD]: 4.3) (median: 0.5 years, interquartile range [IQR]: 0.3–1.5 years) and gestational age of 33.8 weeks (SD: 5.9) (median: 36 weeks, IQR: 28–39 weeks). At initial DL, 24% ( N = 34) had subglottic injury and 26% ( N = 37) developed SGS. The incidence of SGS after tracheostomy was 11.5 cases per 100 patients per year. At tracheostomy, lower birth weight (1.8 vs. 2.3 kg, p = 0.005), shorter gestational age (31.8 vs. 34.6 weeks, p = 0.01), younger age (0.8 vs. 2.9 years, p = 0.01), lower weight (5.8 vs. 14.7 kg, p = 0.01), and subglottic injury (44% vs. 21%, p = 0.01) were associated with the development of SGS. Multivariable logistic regression analysis associated birth weight (odds ratio [OR]: 0.49, 95% confidence interval [CI]: 0.31–0.75, p = 0.001) and early subglottic injury (OR: 3.22, 95% CI: 1.31–7.88, p = 0.01) with SGS development. Conclusions The incidence of SGS after pediatric tracheostomy is estimated at 11.5 cases per 100 patients per year. Low birth weight and subglottic injury at the time of tracheostomy were associated with SGS in this vulnerable population of children. Level of Evidence 3 Laryngoscope , 2024

Year:

2024

Objectives Posterior glottic diastasis (PGD) is an underappreciated etiology of dysphonia in patients with prior airway reconstruction or prolonged intubation. In endoscopic posterior cricoid reduction (ePCR), cricoid is removed to minimize the posterior glottic gap. Dynamic voice computed tomography (DVCT) permits visualization of the posterior glottis, estimating the amount of cricoid to be removed. Posterior glottic gaps in patients undergoing ePCR were compared to non‐dysphonic patients to describe pediatric PGD and establish surgical parameters for ePCR. Methods DVCTs performed in non‐dysphonic patients and dysphonic patients undergoing ePCR from 2014 to 2023 were reviewed. EPCR operative reports were queried. Pre‐ and postoperative Pediatric Voice Handicap Index (pVHI) and Consensus Auditory‐Perceptual Evaluation of Voice (CAPE‐V) scores and aerodynamic measures were reviewed. Results Seventeen pediatric patients who underwent ePCR and 19 non‐dysphonic patients were included. Posterior glottic gaps were significantly larger in the dysphonic group (median 2.4 mm [IQR: 2.0, 2.8] vs. 1.3 mm [IQR: 1.1, 1.7], p < 0.001). Mean width of the cricoid removed was 1.6 mm (SD 0.4 mm). Mean (SD) pre‐ and postoperative pVHI scores were 55.5 (19.9) and 34.6 (16.0; p < 0.001). Mean (SD) pre‐ and postoperative CAPE‐V scores were 52.7 (15.4) and 36.5 (20.4; p < 0.001), respectively. Conclusions Children in this cohort tolerated an average 1.3 mm posterior glottic gap without dysphonia. Dysphonic patients with PGD had a median 2.4 mm gap and underwent cricoid reduction by 1.6 mm. All ePCR patients demonstrated improvement in dysphonia. Results seek to optimize the management of pediatric PGD and present a safe and effective amount of cricoid to remove during ePCR. Level of Evidence 4 Laryngoscope , 134:5139–5144, 2024

Year:

2024

Objective To determine whether injection laryngoplasty (IL) resolves thin liquid aspiration among children with unilateral vocal cord paralysis (UVCP) after cardiac surgery. Study Design Retrospective case‐control. Setting Tertiary children's hospital. Methods Consecutive children (<5 years) between 2012 and 2022 with UVCP after cardiac surgery were included. Resolution of thin liquid aspiration after IL versus observation was determined for children obtaining videofluoroscopic swallow studies (VFSS). Results A total of 32 children with left UVCP after cardiac surgery met inclusion. Initial surgeries were N = 9 (28%) patent ductus arteriosus ligations, N = 7 (22%) aortic arch surgeries, N = 9 (28%) surgeries for hypoplastic left heart syndrome, and N = 7 (22%) other cardiac surgeries. The mean age at initial surgery was 1.8 months (SD: 3.7). All children had a VFSS obtained after surgery that confirmed aspiration. There were 17 children that obtained an IL at 33.6 months (SD: 20.9) after cardiac surgery and 15 children observed without IL procedure. No surgical complications after IL were noted. The rate of aspiration resolution based on postoperative VFSS was N = 14 (82%) for the IL group and N = 9 (60%) for the control group P = .24. Documented VFSS aspiration resolution after cardiac surgery occurred by 9.6 months (SD: 10.0) in the observation group and 47.4 months (SD: 24.1) in the IL group ( P < .001). Conclusion IL can help treat aspiration in children with UVCP after cardiac surgery but the benefit beyond observation remains unclear. Future studies should continue to explore the utility for IL in managing dysphagia in this pediatric population.

Year:

2024

Objectives : To determine the time to ventilator liberation and decannulation after tracheostomy placement in children with bronchopulmonary dysplasia (BPD) and pulmonary hypertension. Methods: A prospective cohort study included all children (<18 years old) who underwent tracheostomy between 2015 and 2021 with or without a diagnosis of BPD. The primary outcome measures were times to mechanical ventilator liberation, tracheostomy decannulation, or death with tracheostomy in place. Patient demographics, associated comorbidities, and outcomes were compared between groups. Results: A total of 318 children met inclusion with a median (interquartile, IQR) age at tracheostomy of 6.9 (IQR: 4.1 – 49.2) months and 54% (N=170) were male. A diagnosis of BPD was made for 43% (N=136) and this group was younger at tracheostomy placement (5.2 vs. 24.5 months, P <.001) and more often had pulmonary hypertension (65% vs. 24%, P <.001) than children without BPD. Children with BPD spent a median of 2.92 years (IQR: 1.60 – 4.03) on mechanical ventilation compared to 1.84 years (IQR: 0.84 – 3.60) for children without BPD ( P =.003). Unadjusted estimation of time to decannulation was longer for children with BPD (HR=0.92, 95% CI: 0.62 – 1.38). The adjusted survival analysis for time to mortality included pulmonary hypertension as a variable of significance (aHR= 2.5, 95% CI: 1.43 – 4.40). Conclusion : The presence of BPD is associated with an increased duration of mechanical ventilation and time to tracheostomy decannulation. Pulmonary hypertension is associated with an increased mortality risk among this vulnerable population of children.

Year:

2024

Objective This study aimed to determine the direct costs of pediatric tracheostomy care within a health care system. Study Design Prospective analysis. Setting Academic children's hospital. Methods Costs associated with caring for pediatric tracheostomy patients under 18 years were analyzed between 2015 and 2021. Direct costs were calculated using the Medicare/Medicaid charges‐to‐costs ratio for various visit types. Costs were estimated using generalized linear equations, accounting for confounders. Results A total of 297 children underwent tracheostomy at a median age of 0.94 years. The median follow‐up was 2.5 years, resulting in 13,966 visits (mean = 41). The total cost was $321 million. The initial admission accounted for 72% ($231 million) of costs while other inpatient admissions added 24% ($78 million). Emergency department, observation, and outpatient visits comprised 4% of costs. The length of stay (LOS) was the primary cost driver for inpatient visits. Each additional hospital day increased costs by roughly $1195, and each extra admission added about $130,223 after adjusting for confounders. Respiratory failure and infections were the primary reasons for 67% of subsequent admissions. Conclusion Pediatric tracheostomy care generated over $300 million in direct costs over 5 years. Inpatient stays constituted 96% of these costs, with the LOS being a major factor. To reduce direct health expenditures for these patients, the focus should be on minimizing admissions.

Year:

2024

Year:

2023

Collaborators (2)

Romaine Johnson

MD/MPH Program Director

University of Texas Southwestern Medical Center

UNITED STATES
View details

Stephen Chorney

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details